tiprankstipranks
Harrow Health Inc (HROW)
NASDAQ:HROW

Harrow Health Stock Analysis & Ratings

HROW Stock Chart & Stats

Day’s Range$5.72 - $5.97
52-Week Range$5.40 - $12.99
Previous Close$5.85
Volume156.59K
Average Volume (3M)83.43K
Market Cap$156.24M
P/E Ratio-7.4
Beta0.91
Next EarningsAug 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score4
EPS (TTM)-0.78


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

HROW FAQ

What was Harrow Health’s price range in the past 12 months?
Harrow Health lowest stock price was $5.40 and its highest was $12.99 in the past 12 months.
    What is Harrow Health’s market cap?
    Harrow Health’s market cap is $156.24M.
      What is Harrow Health’s price target?
      The average price target for Harrow Health is $16.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $16.00 ,the lowest forecast is $16.00. The average price target represents 176.82% Increase from the current price of $5.78.
        What do analysts say about Harrow Health?
        Harrow Health’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
          When is Harrow Health’s upcoming earnings report date?
          Harrow Health’s upcoming earnings report date is Aug 10, 2022 which is in 84 days.
            How were Harrow Health’s earnings last quarter?
            Harrow Health released its earnings results on May 05, 2022. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.035 by -$0.055.
              Is Harrow Health overvalued?
              According to Wall Street analysts Harrow Health’s price is currently Undervalued.
                Does Harrow Health pay dividends?
                Harrow Health does not currently pay dividends.
                What is Harrow Health’s EPS estimate?
                Harrow Health’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Harrow Health have?
                Harrow Health has 27,030,000 shares outstanding.
                  What happened to Harrow Health’s price movement after its last earnings report?
                  Harrow Health reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.035. Following the earnings report the stock price went up 6.386%.
                    Which hedge fund is a major shareholder of Harrow Health?
                    Among the largest hedge funds holding Harrow Health’s share is Ardsley Advisory Partners. It holds Harrow Health’s shares valued at N/A.

                      ---

                      Harrow Health Stock Analysis

                      The Harrow Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Harrow Health Inc

                      Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Travere Therapeutics

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis